Assay of colistin A, B and colistin methanesulfonate in human plasma by LC-MS/MS and short-term plasma stability

Warning

This publication doesn't include Faculty of Education. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

KUBÍČKOVÁ Vendula SOUKOP Jan RYCHLÍČKOVÁ Jitka

Year of publication 2023
Type Article in Periodical
Magazine / Source Klinicka Farmakologie a Farmacie
MU Faculty or unit

Faculty of Medicine

Citation
Web https://www.klinickafarmakologie.cz/pdfs/far/2023/03/02.pdf
Doi http://dx.doi.org/10.36290/far.2023.016
Keywords colistin; CMS; quantification methods; clinical samples; critically ill
Description A simple liquid chromatography tandem mass spectrometry (LC-MS/MS) assay for the determination of colistin A and colistin B in human plasma was developed and validated. Plasma extraction was performed using Oasis HLB 1 ml cartridges, analysis was performed using Arion® Polar C18 (250×4,6mm; 5mm) column at 35°C. Mobile phases consisted of water containing 0,1% formic acid and methanol containing 0,1% formic acid (40:60, v/v) delivered at a flow rate of 0,8 ml/minute. Eluent was detected in the positive ion mode using electrospray ionization at the following transitions of mass to charge (m/z): colistin A 585,55 › 101,05; colistin B 578,5 › 101,15; and IS 602,4 › 101,1; 120,15; 86,15. Short-term stability tests of colistin and CMS were performed, at room temperature and 37°C, where the stability of both components decreases with increasing temperature. The presented paper is part of the Pharmacokinetics of Colistin in Critically Ill Patients With Extracorporeal Membrane Oxygenation (COL-ECMO2022) study in which further results will be presented.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.